Edition:
United Kingdom

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

13.84USD
15 Feb 2019
Change (% chg)

$-0.37 (-2.60%)
Prev Close
$14.21
Open
$14.35
Day's High
$14.44
Day's Low
$13.63
Volume
98,697
Avg. Vol
111,533
52-wk High
$31.69
52-wk Low
$11.45

Chart for

About

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The... (more)

Overall

No Ratios Available.

Financials

  APLS.OQ Industry Sector
P/E (TTM): -- 30.48 33.70
EPS (TTM): -- -- --
ROI: -- 14.95 14.45
ROE: -- 16.27 15.96

Earnings vs. Estimates